October 1, 2015
September 28, 2015
September 16, 2015
“A company in a pre-launch phase has the ability to create foundational value by educating stakeholders within the scientific and medical community about their novel therapeutic approach. At InVivo, we believe surgical implantation of the Neuro-Spinal Scaffold™ device has the potential to establish a beneficial paradigm shift in the treatment of acute spinal cord injury (SCI). However, it is our responsibility to increase awareness of our approach within the clinical community…” For full text, click here.
Mark Perrin, CEO and Chairman, 9/21/2015